Neurocrine Biosciences, Inc.
DE ˙ DB ˙ US64125C1099
134,65 € ↑0,30 (0,22%)
2026-06-03
DEL PRIS
SecurityDE:NB3 / Neurocrine Biosciences, Inc.
InstitutionSquarepoint Ops LLC
Latest Disclosed Ownership487,953 shares
Latest Disclosed Value $ 64,282,928
Squarepoint Ops LLC ownership in NB3 / Neurocrine Biosciences, Inc.

On May 15, 2026 - Squarepoint Ops LLC filed a 13F-HR form disclosing ownership of 487,953 shares of Neurocrine Biosciences, Inc. (DE:NB3) valued at $54,528,748 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 209,706 shares of Neurocrine Biosciences, Inc.. This represents a change in shares of 132.68% during the quarter. The current value of the position is $65,702,871 USD.

Squarepoint Ops LLC has a history of taking positions in derivatives of the underlying security (NB3) in the form of stock options.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:NB3 / Neurocrine Biosciences, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 487,953 278,247 132.68 64,283 116.13 0.0755
2026-02-13 2025-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 209,706 169,225 418.04 29,743 423.44 0.0316
2025-11-14 2025-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 40,481 -126,121 -75.70 5,683 -72.87 0.0057
2025-08-27 2025-06-30 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 166,602 166,602 20,940 0.0218
2025-08-14 2025-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 166,602 166,602 20,940 0.0218
2025-02-14 2024-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 0 -68,369 -100.00 0 -100.00
2024-11-14 2024-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 68,369 68,369 7,877 0.0123
2024-08-14 2024-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 0 -30,806 -100.00 0 -100.00
2024-05-15 2024-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 30,806 -49,375 -61.58 4,249 -59.79 0.0073
2024-02-14 2023-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 80,181 51,830 182.82 10,565 231.26 0.0200
2023-11-14 2023-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 28,351 -89,646 -75.97 3,189 -71.34 0.0079
2023-08-14 2023-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 117,997 -47,839 -28.85 11,127 -33.71 0.0341
2023-05-15 2023-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 165,836 132,314 394.71 16,786 319.31 0.0684
2023-02-14 2022-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 33,522 -24,138 -41.86 4,004 -34.63 0.0158
2022-11-14 2022-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 57,660 44,656 343.40 6,124 382.97 0.0309
2022-08-15 2022-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 13,004 -84,440 -86.65 1,268 -86.12 0.0071
2022-05-16 2022-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 97,444 35,300 56.80 9,135 72.59 0.0391
2022-02-14 2021-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 62,144 44,657 255.37 5,293 215.62 0.0140
2021-11-15 2021-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 17,487 -1,753 -9.11 1,677 -10.42 0.0048
2021-08-16 2021-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 19,240 16,393 575.80 1,872 575.81 0.0071
2021-05-17 2021-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 2,847 -1,197 -29.60 277 -28.61 0.0016
2021-02-16 2020-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 4,044 -9,795 -70.78 388 -70.85 0.0029
2020-11-16 2020-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 13,839 13,839 1,331 0.0179
2020-08-14 2020-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 0 -31,660 -100.00 0 -100.00
2020-05-15 2020-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 31,660 -52,824 -62.53 2,740 -69.83 0.0701
2020-02-14 2019-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 84,484 -81,220 -49.02 9,081 -39.18 0.0540
2019-11-14 2019-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 165,704 127,195 330.30 14,932 359.30 0.1333
2019-08-14 2019-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 38,509 -73,922 -65.75 3,251 -67.18 0.0317
2019-05-15 2019-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 112,431 -29,583 -20.83 9,905 -2.33 0.1049
2019-02-14 2018-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 142,014 134,539 1,799.85 10,141 1,003.48 0.1180
2018-11-14 2018-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 7,475 2,183 41.25 919 76.73 0.0110
2018-08-14 2018-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 5,292 1,159 28.04 520 51.60 0.0069
2018-05-15 2018-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 4,133 -76,098 -94.85 343 -94.49 0.0054
2018-02-14 2017-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 80,231 60,328 303.11 6,225 410.25 0.1085
2017-11-14 2017-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 19,903 15,465 348.47 1,220 498.04 0.0235
2017-08-14 2017-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 4,438 4,438 204 0.0040
2017-02-14 2016-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 0 -24,611 -100.00 0 -100.00
2016-11-14 2016-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 24,611 -41,289 -62.65 1,247 -58.36 0.0828
2016-08-15 2016-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 65,900 65,900 0.00 2,995 0.1869
2016-05-16 2016-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 0 -5,300 -100.00 0 -100.00
2016-02-16 2015-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 5,300 5,300 300 0.0329
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-08-27 2025-03-31 13F/A NEUROCRINE BIOSCIENCES COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-15 2025-03-31 13F NEUROCRINE BIOSCIENCES COM Put 0 0 n/a n/a n/a
2025-02-14 2024-12-31 13F NEUROCRINE BIOSCIENCES COM Put 4,300 587 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.